After searching i can't believe there's no thread on this one.

Anyhow what about a bounce for tomorrow after some sort of analysts meeting?

Regards

Stan.

Tate & Lyle PLC


29 September 2005 - Tate & Lyle PLC

Trading Update

In line with its regular practice, Tate & Lyle issues the following trading
update prior to meeting with stockbrokers' analysts and entering a closed period
in respect of the interim results to 30 September 2005. The interim results will
be announced on 3 November 2005.

Trading since the update issued on 28 July 2005, prior to the Annual General
Meeting, has continued to be in line with our internal expectations. Over the
five months to 31 August 2005, profit before tax and amortisation has met our
budgetary expectations and is modestly above the corresponding period of the
prior year, despite higher interest charges as we invest for growth.

SPLENDA Sucralose has continued to enjoy strong demand across all major food,
beverage and pharmaceutical categories. Similar to 2005, demand from existing
customers is expected to outpace production through the year to March 2006. The
expansion projects to increase sucralose production capacity in Alabama, USA and
Singapore are on schedule and the related capital expenditure is in line with
budget.

We are aware that a no-calorie sweetener tabletop product containing sucralose
and called 'Altern' has been available in one or two stores in the USA. We have
determined that the sucralose contained in the product was manufactured in our
facility in McIntosh, Alabama. This product has now been withdrawn from sale.

Food & Industrial Ingredients Americas has again demonstrated good growth in
value added food ingredients. Industrial ingredients have performed as planned
in difficult market conditions. Ethanol has benefited from increased margins in
recent months. Commodity sweetener volumes have exceeded our expectations whilst
margins have been stable. The citric acid product line has contributed increased
profitability. Increased costs, in particular energy and transport, have
partially eroded margin gains in this division. As expected, small start up
losses have been incurred on both AquastaTM astaxanthin and the Bio-PDO (Bio-3G)
joint ventures.

Food & Industrial Ingredients Europe has achieved higher sales volumes with good
growth in food ingredients. This benefit has been partially offset by lower
sweetener selling prices and margins following the 2005 calendar year pricing
round, and higher costs, particularly energy and transport. These cost increases
will affect second half performance and will need to be recovered in the 2006
calendar year pricing round.

Profitability in our EU sugar refining business has been substantially reduced
with oversupply in the market coupled with the expected higher cost of export
licenses. Energy costs were also higher. This profit reduction has partially
been offset by a good performance in sugar trading. A fire in our Portuguese
refinery resulted in a loss of raw sugar stock which resulted in a small loss in
our re-insurance operation. In Canada, performance has been as expected, but
below the level of the comparative period.

Overall, our expectations for the full financial year to March 2006 remain
unchanged. Looking further forward, if prevailing energy prices persist through
our financial year 2007 it would increase our costs by around 40 million. We
aim to recover this through product pricing.

There has not been any new information or clarification on the proposals for
reform of the EU sugar regime which were tabled by the European Commission on 22
June 2005. Our efforts to achieve an equitable solution for our businesses
continue. We expect the Commission to announce final proposals for the EU Sugar
Regime towards the end of November 2005.

Is anybody else following these? This may well start heading up towards the interims on 3rd Nov and even higher if the results are good.

http://www.latimes.com/business/printedition/la-ft-splenda10oct10,1,3593285.story?coll=la-headlines-pe-business

Broker Roundup: Numis recommends Tate after analyst visit
Published: 09:43 Monday 17 October 2005
By: Phil Cozens, Stockmarket Correspondent

Numis has a buy rating and 552p price target for Tate and Lyle after analyst visit to the US.

is this worth buying now? big spike down for a big boy

sp fell as far as 378 this morning and has now rallied to 401, but this a thumping loss ...... the chart is meaningless, but looking back a long way, there is arguably support at about 360, but there should have been much better support at 440, but sp didn't even blink on the way down and through.

my gut feeling is that as a trade there may well be scope, but as an investment, there has to be better to choose.

SV,

In a rising market I would be looking at these as a recovery play but in this "iffy" market I will pass.

Sentiment towards the dollar is not likely to improve short term but TATE is one to put on the watch list, hopefully to bottom fish. Good quality brand name and management,s continued concentration on higher margin products will be noticed by longer term investors.

Long term I wouldn't disagree GC but short term the market is very unforgiving at the moment, hence the punishing drop. Another reason for the drop is the price hike in raw materials worldwide.

tate have now had 3 profit warnings and there is no obvious good news in the immediate future ..... not a good investment, even if there is a quick bounce as some short postions are closed.

Any chance of two quid again?

If yes, there I will be again.

I will be shorting Tate & Lyle from Monday. Currently 402p closed on Friday. This has much more downside. Short it now.

You may be right short term but be careful you are not caught out by an oportunistic bid. Sharehoders funds 1billion market cap 2billion dividend safe as reserves more than adequate.

bid by whom?

richard have a look in your email box

Cynic how about ABF for starters?

janet .... have read and will reply tomorrow

I would not be surprised if they fall again tomorrow.

Bit out of contact with TATE over the last year and did not realise this was their 3rd warning.

"A boardroom shake-up is likely to be demanded this week by lead investors in the embattled sugar group, Tate & Lyle, following the company's third profits warning in a year, says the Sunday Independent."

..In view of that you could well be right Mitzy.

Keep on shorting TATE and you'll be in profit